Service & Software

Global AI Pharmaceutical Market Research Report 2026

This report delivers a comprehensive overview of the global AI Pharmaceutical market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding AI Pharmaceutical. The AI Pharmaceutical market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global AI Pharmaceutical market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist AI Pharmaceutical manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Noetik
Atomwise
Cradle
Exscientia
Iktos
Insilico Medicine
BenevolentAI
Cyclica
Recursion
Auransa
InveniAI
Pfizer
IBM
Segment by Type
Artificial intelligence (AI)
Machine Learning (ML)
Others
Segment by Application
Drug Discovery
Clinical Trials
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for AI Pharmaceutical companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI Pharmaceutical Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Artificial intelligence (AI)
1.2.3 Machine Learning (ML)
1.2.4 Others
1.3 Market by Application
1.3.1 Global AI Pharmaceutical Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Drug Discovery
1.3.3 Clinical Trials
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI Pharmaceutical Market Perspective (2021–2032)
2.2 Global AI Pharmaceutical Growth Trends by Region
2.2.1 Global AI Pharmaceutical Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 AI Pharmaceutical Historic Market Size by Region (2021–2026)
2.2.3 AI Pharmaceutical Forecasted Market Size by Region (2027–2032)
2.3 AI Pharmaceutical Market Dynamics
2.3.1 AI Pharmaceutical Industry Trends
2.3.2 AI Pharmaceutical Market Drivers
2.3.3 AI Pharmaceutical Market Challenges
2.3.4 AI Pharmaceutical Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI Pharmaceutical Players by Revenue
3.1.1 Global Top AI Pharmaceutical Players by Revenue (2021–2026)
3.1.2 Global AI Pharmaceutical Revenue Market Share by Players (2021–2026)
3.2 Global Top AI Pharmaceutical Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by AI Pharmaceutical Revenue
3.4 Global AI Pharmaceutical Market Concentration Ratio
3.4.1 Global AI Pharmaceutical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI Pharmaceutical Revenue in 2025
3.5 Global Key Players of AI Pharmaceutical Head Offices and Areas Served
3.6 Global Key Players of AI Pharmaceutical, Products and Applications
3.7 Global Key Players of AI Pharmaceutical, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 AI Pharmaceutical Breakdown Data by Type
4.1 Global AI Pharmaceutical Historic Market Size by Type (2021–2026)
4.2 Global AI Pharmaceutical Forecasted Market Size by Type (2027–2032)
5 AI Pharmaceutical Breakdown Data by Application
5.1 Global AI Pharmaceutical Historic Market Size by Application (2021–2026)
5.2 Global AI Pharmaceutical Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America AI Pharmaceutical Market Size (2021–2032)
6.2 North America AI Pharmaceutical Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America AI Pharmaceutical Market Size by Country (2021–2026)
6.4 North America AI Pharmaceutical Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI Pharmaceutical Market Size (2021–2032)
7.2 Europe AI Pharmaceutical Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe AI Pharmaceutical Market Size by Country (2021–2026)
7.4 Europe AI Pharmaceutical Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific AI Pharmaceutical Market Size (2021–2032)
8.2 Asia-Pacific AI Pharmaceutical Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific AI Pharmaceutical Market Size by Region (2021–2026)
8.4 Asia-Pacific AI Pharmaceutical Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America AI Pharmaceutical Market Size (2021–2032)
9.2 Latin America AI Pharmaceutical Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America AI Pharmaceutical Market Size by Country (2021–2026)
9.4 Latin America AI Pharmaceutical Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI Pharmaceutical Market Size (2021–2032)
10.2 Middle East & Africa AI Pharmaceutical Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa AI Pharmaceutical Market Size by Country (2021–2026)
10.4 Middle East & Africa AI Pharmaceutical Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Noetik
11.1.1 Noetik Company Details
11.1.2 Noetik Business Overview
11.1.3 Noetik AI Pharmaceutical Introduction
11.1.4 Noetik Revenue in AI Pharmaceutical Business (2021–2026)
11.1.5 Noetik Recent Development
11.2 Atomwise
11.2.1 Atomwise Company Details
11.2.2 Atomwise Business Overview
11.2.3 Atomwise AI Pharmaceutical Introduction
11.2.4 Atomwise Revenue in AI Pharmaceutical Business (2021–2026)
11.2.5 Atomwise Recent Development
11.3 Cradle
11.3.1 Cradle Company Details
11.3.2 Cradle Business Overview
11.3.3 Cradle AI Pharmaceutical Introduction
11.3.4 Cradle Revenue in AI Pharmaceutical Business (2021–2026)
11.3.5 Cradle Recent Development
11.4 Exscientia
11.4.1 Exscientia Company Details
11.4.2 Exscientia Business Overview
11.4.3 Exscientia AI Pharmaceutical Introduction
11.4.4 Exscientia Revenue in AI Pharmaceutical Business (2021–2026)
11.4.5 Exscientia Recent Development
11.5 Iktos
11.5.1 Iktos Company Details
11.5.2 Iktos Business Overview
11.5.3 Iktos AI Pharmaceutical Introduction
11.5.4 Iktos Revenue in AI Pharmaceutical Business (2021–2026)
11.5.5 Iktos Recent Development
11.6 Insilico Medicine
11.6.1 Insilico Medicine Company Details
11.6.2 Insilico Medicine Business Overview
11.6.3 Insilico Medicine AI Pharmaceutical Introduction
11.6.4 Insilico Medicine Revenue in AI Pharmaceutical Business (2021–2026)
11.6.5 Insilico Medicine Recent Development
11.7 BenevolentAI
11.7.1 BenevolentAI Company Details
11.7.2 BenevolentAI Business Overview
11.7.3 BenevolentAI AI Pharmaceutical Introduction
11.7.4 BenevolentAI Revenue in AI Pharmaceutical Business (2021–2026)
11.7.5 BenevolentAI Recent Development
11.8 Cyclica
11.8.1 Cyclica Company Details
11.8.2 Cyclica Business Overview
11.8.3 Cyclica AI Pharmaceutical Introduction
11.8.4 Cyclica Revenue in AI Pharmaceutical Business (2021–2026)
11.8.5 Cyclica Recent Development
11.9 Recursion
11.9.1 Recursion Company Details
11.9.2 Recursion Business Overview
11.9.3 Recursion AI Pharmaceutical Introduction
11.9.4 Recursion Revenue in AI Pharmaceutical Business (2021–2026)
11.9.5 Recursion Recent Development
11.10 Auransa
11.10.1 Auransa Company Details
11.10.2 Auransa Business Overview
11.10.3 Auransa AI Pharmaceutical Introduction
11.10.4 Auransa Revenue in AI Pharmaceutical Business (2021–2026)
11.10.5 Auransa Recent Development
11.11 InveniAI
11.11.1 InveniAI Company Details
11.11.2 InveniAI Business Overview
11.11.3 InveniAI AI Pharmaceutical Introduction
11.11.4 InveniAI Revenue in AI Pharmaceutical Business (2021–2026)
11.11.5 InveniAI Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer AI Pharmaceutical Introduction
11.12.4 Pfizer Revenue in AI Pharmaceutical Business (2021–2026)
11.12.5 Pfizer Recent Development
11.13 IBM
11.13.1 IBM Company Details
11.13.2 IBM Business Overview
11.13.3 IBM AI Pharmaceutical Introduction
11.13.4 IBM Revenue in AI Pharmaceutical Business (2021–2026)
11.13.5 IBM Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global AI Pharmaceutical Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Artificial intelligence (AI)
Table 3. Key Players of Machine Learning (ML)
Table 4. Key Players of Others
Table 5. Global AI Pharmaceutical Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global AI Pharmaceutical Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global AI Pharmaceutical Market Size by Region (US$ Million), 2021–2026
Table 8. Global AI Pharmaceutical Market Share by Region (2021–2026)
Table 9. Global AI Pharmaceutical Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global AI Pharmaceutical Market Share by Region (2027–2032)
Table 11. AI Pharmaceutical Market Trends
Table 12. AI Pharmaceutical Market Drivers
Table 13. AI Pharmaceutical Market Challenges
Table 14. AI Pharmaceutical Market Restraints
Table 15. Global AI Pharmaceutical Revenue by Players (US$ Million), 2021–2026
Table 16. Global AI Pharmaceutical Market Share by Players (2021–2026)
Table 17. Global Top AI Pharmaceutical Players by Tier (Tier 1, Tier 2, and Tier 3), based on AI Pharmaceutical Revenue, 2025
Table 18. Ranking of Global Top AI Pharmaceutical Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by AI Pharmaceutical Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of AI Pharmaceutical, Headquarters and Area Served
Table 21. Global Key Players of AI Pharmaceutical, Products and Applications
Table 22. Global Key Players of AI Pharmaceutical, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global AI Pharmaceutical Market Size by Type (US$ Million), 2021–2026
Table 25. Global AI Pharmaceutical Revenue Market Share by Type (2021–2026)
Table 26. Global AI Pharmaceutical Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global AI Pharmaceutical Revenue Market Share by Type (2027–2032)
Table 28. Global AI Pharmaceutical Market Size by Application (US$ Million), 2021–2026
Table 29. Global AI Pharmaceutical Revenue Market Share by Application (2021–2026)
Table 30. Global AI Pharmaceutical Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global AI Pharmaceutical Revenue Market Share by Application (2027–2032)
Table 32. North America AI Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America AI Pharmaceutical Market Size by Country (US$ Million), 2021–2026
Table 34. North America AI Pharmaceutical Market Size by Country (US$ Million), 2027–2032
Table 35. Europe AI Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe AI Pharmaceutical Market Size by Country (US$ Million), 2021–2026
Table 37. Europe AI Pharmaceutical Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific AI Pharmaceutical Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific AI Pharmaceutical Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific AI Pharmaceutical Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America AI Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America AI Pharmaceutical Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America AI Pharmaceutical Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa AI Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa AI Pharmaceutical Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa AI Pharmaceutical Market Size by Country (US$ Million), 2027–2032
Table 47. Noetik Company Details
Table 48. Noetik Business Overview
Table 49. Noetik AI Pharmaceutical Product
Table 50. Noetik Revenue in AI Pharmaceutical Business (US$ Million), 2021–2026
Table 51. Noetik Recent Development
Table 52. Atomwise Company Details
Table 53. Atomwise Business Overview
Table 54. Atomwise AI Pharmaceutical Product
Table 55. Atomwise Revenue in AI Pharmaceutical Business (US$ Million), 2021–2026
Table 56. Atomwise Recent Development
Table 57. Cradle Company Details
Table 58. Cradle Business Overview
Table 59. Cradle AI Pharmaceutical Product
Table 60. Cradle Revenue in AI Pharmaceutical Business (US$ Million), 2021–2026
Table 61. Cradle Recent Development
Table 62. Exscientia Company Details
Table 63. Exscientia Business Overview
Table 64. Exscientia AI Pharmaceutical Product
Table 65. Exscientia Revenue in AI Pharmaceutical Business (US$ Million), 2021–2026
Table 66. Exscientia Recent Development
Table 67. Iktos Company Details
Table 68. Iktos Business Overview
Table 69. Iktos AI Pharmaceutical Product
Table 70. Iktos Revenue in AI Pharmaceutical Business (US$ Million), 2021–2026
Table 71. Iktos Recent Development
Table 72. Insilico Medicine Company Details
Table 73. Insilico Medicine Business Overview
Table 74. Insilico Medicine AI Pharmaceutical Product
Table 75. Insilico Medicine Revenue in AI Pharmaceutical Business (US$ Million), 2021–2026
Table 76. Insilico Medicine Recent Development
Table 77. BenevolentAI Company Details
Table 78. BenevolentAI Business Overview
Table 79. BenevolentAI AI Pharmaceutical Product
Table 80. BenevolentAI Revenue in AI Pharmaceutical Business (US$ Million), 2021–2026
Table 81. BenevolentAI Recent Development
Table 82. Cyclica Company Details
Table 83. Cyclica Business Overview
Table 84. Cyclica AI Pharmaceutical Product
Table 85. Cyclica Revenue in AI Pharmaceutical Business (US$ Million), 2021–2026
Table 86. Cyclica Recent Development
Table 87. Recursion Company Details
Table 88. Recursion Business Overview
Table 89. Recursion AI Pharmaceutical Product
Table 90. Recursion Revenue in AI Pharmaceutical Business (US$ Million), 2021–2026
Table 91. Recursion Recent Development
Table 92. Auransa Company Details
Table 93. Auransa Business Overview
Table 94. Auransa AI Pharmaceutical Product
Table 95. Auransa Revenue in AI Pharmaceutical Business (US$ Million), 2021–2026
Table 96. Auransa Recent Development
Table 97. InveniAI Company Details
Table 98. InveniAI Business Overview
Table 99. InveniAI AI Pharmaceutical Product
Table 100. InveniAI Revenue in AI Pharmaceutical Business (US$ Million), 2021–2026
Table 101. InveniAI Recent Development
Table 102. Pfizer Company Details
Table 103. Pfizer Business Overview
Table 104. Pfizer AI Pharmaceutical Product
Table 105. Pfizer Revenue in AI Pharmaceutical Business (US$ Million), 2021–2026
Table 106. Pfizer Recent Development
Table 107. IBM Company Details
Table 108. IBM Business Overview
Table 109. IBM AI Pharmaceutical Product
Table 110. IBM Revenue in AI Pharmaceutical Business (US$ Million), 2021–2026
Table 111. IBM Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 115. Authors List of This Report


List of Figures
Figure 1. AI Pharmaceutical Picture
Figure 2. Global AI Pharmaceutical Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global AI Pharmaceutical Market Share by Type: 2025 vs 2032
Figure 4. Artificial intelligence (AI) Features
Figure 5. Machine Learning (ML) Features
Figure 6. Others Features
Figure 7. Global AI Pharmaceutical Market Size by Application (US$ Million), 2021–2032
Figure 8. Global AI Pharmaceutical Market Share by Application: 2025 vs 2032
Figure 9. Drug Discovery Case Studies
Figure 10. Clinical Trials Case Studies
Figure 11. Others Case Studies
Figure 12. AI Pharmaceutical Report Years Considered
Figure 13. Global AI Pharmaceutical Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global AI Pharmaceutical Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global AI Pharmaceutical Market Share by Region: 2025 vs 2032
Figure 16. Global AI Pharmaceutical Market Share by Players in 2025
Figure 17. Global AI Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by AI Pharmaceutical Revenue in 2025
Figure 19. North America AI Pharmaceutical Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America AI Pharmaceutical Market Share by Country (2021–2032)
Figure 21. United States AI Pharmaceutical Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada AI Pharmaceutical Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe AI Pharmaceutical Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe AI Pharmaceutical Market Share by Country (2021–2032)
Figure 25. Germany AI Pharmaceutical Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France AI Pharmaceutical Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. AI Pharmaceutical Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy AI Pharmaceutical Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia AI Pharmaceutical Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland AI Pharmaceutical Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific AI Pharmaceutical Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific AI Pharmaceutical Market Share by Region (2021–2032)
Figure 33. China AI Pharmaceutical Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan AI Pharmaceutical Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea AI Pharmaceutical Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia AI Pharmaceutical Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India AI Pharmaceutical Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand AI Pharmaceutical Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America AI Pharmaceutical Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America AI Pharmaceutical Market Share by Country (2021–2032)
Figure 41. Mexico AI Pharmaceutical Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil AI Pharmaceutical Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa AI Pharmaceutical Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa AI Pharmaceutical Market Share by Country (2021–2032)
Figure 45. Israel AI Pharmaceutical Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia AI Pharmaceutical Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE AI Pharmaceutical Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Noetik Revenue Growth Rate in AI Pharmaceutical Business (2021–2026)
Figure 49. Atomwise Revenue Growth Rate in AI Pharmaceutical Business (2021–2026)
Figure 50. Cradle Revenue Growth Rate in AI Pharmaceutical Business (2021–2026)
Figure 51. Exscientia Revenue Growth Rate in AI Pharmaceutical Business (2021–2026)
Figure 52. Iktos Revenue Growth Rate in AI Pharmaceutical Business (2021–2026)
Figure 53. Insilico Medicine Revenue Growth Rate in AI Pharmaceutical Business (2021–2026)
Figure 54. BenevolentAI Revenue Growth Rate in AI Pharmaceutical Business (2021–2026)
Figure 55. Cyclica Revenue Growth Rate in AI Pharmaceutical Business (2021–2026)
Figure 56. Recursion Revenue Growth Rate in AI Pharmaceutical Business (2021–2026)
Figure 57. Auransa Revenue Growth Rate in AI Pharmaceutical Business (2021–2026)
Figure 58. InveniAI Revenue Growth Rate in AI Pharmaceutical Business (2021–2026)
Figure 59. Pfizer Revenue Growth Rate in AI Pharmaceutical Business (2021–2026)
Figure 60. IBM Revenue Growth Rate in AI Pharmaceutical Business (2021–2026)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies